[Table/Fig-3]:
Parameter | Study groups | Mean±SD | p value |
---|---|---|---|
Mean vascular density | Control | 13.83±2.64 | <0.001* |
Stage I OSMF | 17.02±4.72 | ||
Stage II OSMF | 12.80±2.61 | ||
Stage III OSMF | 9.52±1.28 | ||
Total vascular area | Control | 3579.13±1608.28 | <0.001* |
Stage I OSMF | 2876.73±1381.36 | ||
Stage II OSMF | 1996.57±886.37 | ||
Stage III OSMF | 608.56±160.34 | ||
Mean vascular area | Control | 251.82±98.94 | <0.001* |
Stage I OSMF | 187.25±119.11 | ||
Stage II OSMF | 160.00±75.76 | ||
Stage III OSMF | 65.41±21.40 |
Statistically significant; p value obtained using ‘Kruskal Walllis test’.